These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22230199)

  • 61. New developments in the discovery of small molecule Hedgehog pathway antagonists.
    Tremblay MR; McGovern K; Read MA; Castro AC
    Curr Opin Chem Biol; 2010 Jun; 14(3):428-35. PubMed ID: 20399136
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Conformational ensembles, signal transduction and residue hot spots: application to drug discovery.
    Acuner Ozbabacan SE; Gursoy A; Keskin O; Nussinov R
    Curr Opin Drug Discov Devel; 2010 Sep; 13(5):527-37. PubMed ID: 20812144
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Probing small molecule-protein interactions: A new perspective for functional proteomics.
    Lenz T; Fischer JJ; Dreger M
    J Proteomics; 2011 Dec; 75(1):100-15. PubMed ID: 21835278
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Identification of protein-protein interactions by surface plasmon resonance followed by mass spectrometry.
    Madeira A; Vikeved E; Nilsson A; Sjögren B; Andrén PE; Svenningsson P
    Curr Protoc Protein Sci; 2011 Aug; Chapter 19():Unit19.21. PubMed ID: 21842469
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Psoromic acid derivatives: a new family of small-molecule pre-mRNA splicing inhibitors discovered by a stage-specific high-throughput in vitro splicing assay.
    Samatov TR; Wolf A; Odenwälder P; Bessonov S; Deraeve C; Bon RS; Waldmann H; Lührmann R
    Chembiochem; 2012 Mar; 13(5):640-4. PubMed ID: 22334518
    [No Abstract]   [Full Text] [Related]  

  • 66. A Guide to Run Affinity Screens Using Differential Scanning Fluorimetry and Surface Plasmon Resonance Assays.
    Bergsdorf C; Wright SK
    Methods Enzymol; 2018; 610():135-165. PubMed ID: 30390797
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Coverage and bias in chemical library design.
    Gregori-Puigjané E; Mestres J
    Curr Opin Chem Biol; 2008 Jun; 12(3):359-65. PubMed ID: 18423416
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Crystallographic fragment screening.
    Badger J
    Methods Mol Biol; 2012; 841():161-77. PubMed ID: 22222452
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Historical overview of chemical library design.
    Dolle RE
    Methods Mol Biol; 2011; 685():3-25. PubMed ID: 20981516
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biased and unbiased strategies to identify biologically active small molecules.
    Abet V; Mariani A; Truscott FR; Britton S; Rodriguez R
    Bioorg Med Chem; 2014 Aug; 22(16):4474-89. PubMed ID: 24811300
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Small-molecule protein-protein interaction inhibitors: therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations.
    Buchwald P
    IUBMB Life; 2010 Oct; 62(10):724-31. PubMed ID: 20979208
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficient hit and lead compound evaluation strategy based on off-rate screening by surface plasmon resonance.
    Liu L
    J Med Chem; 2014 Apr; 57(7):2843-4. PubMed ID: 24654838
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Targeting protein-protein interactions for drug discovery.
    Fry DC
    Methods Mol Biol; 2015; 1278():93-106. PubMed ID: 25859945
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Understanding Protein-Protein Interactions: Essential Players in (Patho)physiology (Part 2).
    Wilson AJ; Gunning PT
    ChemMedChem; 2016 Apr; 11(8):732-3. PubMed ID: 27061459
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Determining the mode of action of bioactive compounds.
    Azad MA; Wright GD
    Bioorg Med Chem; 2012 Mar; 20(6):1929-39. PubMed ID: 22300885
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Off-rate screening (ORS) by surface plasmon resonance. An efficient method to kinetically sample hit to lead chemical space from unpurified reaction products.
    Murray JB; Roughley SD; Matassova N; Brough PA
    J Med Chem; 2014 Apr; 57(7):2845-50. PubMed ID: 24520903
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Challenges in Discovering Drugs That Target the Protein-Protein Interactions of Disordered Proteins.
    Oláh J; Szénási T; Lehotzky A; Norris V; Ovádi J
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163473
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Learning from our mistakes: the 'unknown knowns' in fragment screening.
    Davis BJ; Erlanson DA
    Bioorg Med Chem Lett; 2013 May; 23(10):2844-52. PubMed ID: 23562240
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hide and seek: Identification and confirmation of small molecule protein targets.
    Ursu A; Waldmann H
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3079-86. PubMed ID: 26115575
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Clinical progress and pharmacology of small molecule bromodomain inhibitors.
    Theodoulou NH; Tomkinson NC; Prinjha RK; Humphreys PG
    Curr Opin Chem Biol; 2016 Aug; 33():58-66. PubMed ID: 27295577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.